Background: Physiological changes occur in man during space missions also at the renal level. Proteinuria was hypothesized for space missions but research data are missing. Methods: Urinary albumin, as an index of proteinuria, and other variables were analyzed in 4 astronauts during space missions onboard the MIR station and on the ground (control). Mission duration before first urine collection in the four astronauts was 4, 26, 26, and 106 days, respectively. On the ground, data were collected 2 months before mission in two astronauts, 6 months after in the other astronauts. A total of twenty-two 24-hour urine collections were obtained in space (n per astronaut = 1–14) and on the ground (n per astronaut = 2–12). Urinary albumin was measured by radioimmunoassay. For each astronaut, mean of data in space and on the ground was defined as individual average. Results: The individual averages of 24 h urinary albumin were lower in space than on the ground in all astronauts; the difference was significant (mean ± SD, space and on the ground = 3.41 ± 0.56 and 4.70 ± 1.20 mg/24 h, p = 0.017). Dietary protein intake and 24-hour urinary urea were not significantly different between space and on the ground. Conclusions: Urinary albumin excretion is low during space mission compared to data on the ground before or after mission. Low urinary albumin excretion could be another effect of exposure to weightlessness (microgravity).

1.
Johnson RS, Dietlein LF: Biomedical results from Skylab. NASA SP-377. Washington, US Government Printing Office, 1977.
2.
Leach CS, Alfrey CP, Suki WN, Leonard JI, Rambaut PC, Inners LD, Smith SL, Lane HW, Krauhs JM: Regulation of body fluid compartments during short term space flight. J Appl Physiol 1996;81:105–116.
3.
Drummer C, Hesse C, Baisch F, Norsk P, Elmann-Larsen B, Gerzer R, Heer M: Water- and sodium-balances and their relation to body mass changes in microgravity. Eur J Clin Invest 2000;30:1066–1075.
4.
Norsk P, Christensen NJ, Bie P, Gabrielsen A, Heer M, Drummer C: Unexpected renal responses in space. Lancet 2000;356:1577–1578.
5.
Kramer HJ, Heer M, Cirillo M, De Santo NG: Renal hemodynamics in space. Am J Kidney Dis 2001;38:675–678.
6.
Christensen NJ, Drummer C, Norsk P: Renal and sympathoadrenal responses in space. Am J Kidney Dis 2001;38:669–683.
7.
Drummer C, Norsk P, Heer M: Water and sodium balance in space. Am J Kidney Dis 2001;38:684–699.
8.
Gregoriev AI, Morukov BV, Vorobiev DV: Water and electrolytes studies during long-term missions onboard the space station Salyut and MIR. Clin Invest 1994;72:169–189.
9.
Ruilope LM, Rodicio JL: Microalbuminuria in clinical practice. Kidney Curr Surv Wld Lit 1995;4:211–216.
10.
Cohen DL, Close CF, Viberti GC: The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diab Med 1987;4:437–440.
11.
King AJ, Levey AS: Dietary protein and renal function. J Am Soc Nephrol 1993;3:1723–1737.
12.
Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jacobs C, Bouter LM, Donker AJM, Stehouwer CDA: Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study. Kidney Int 1998;54:203–209.
13.
Heer M, Boerger A, Kamps N, Biener C, Korr C, Drummer C: Nutrient supply during recent European missions. Pflügers Arch 2000;441(suppl):R8–R14.
14.
Baisch F, Beck L, Blomqvist G, Wolfram G, Drescher J, Rome JL, Drummer C: Cardiovascular response to lower body negative pressure stimulation before, during, and after space flight. Eur J Clin Invest 2000;30:1055–1065.
15.
Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG: Microalbuminuria in non-diabetic adults: relation of blood pressure, body mass, plasma cholesterol, and smoking: The Gubbio Population Study. Arch Intern Med 1998;158:1933–1939.
16.
Heer M, De Santo NG, Cirillo M, Drummer C: Body mass changes, energy, and protein metabolism in space. Am J Kidney Dis 2001;38:664–667.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.